表紙
市場調查報告書

急性冠狀動脈症候群治療藥的全球市場

Acute Coronary Syndrome

出版商 Global Industry Analysts, Inc. 商品編碼 912767
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
急性冠狀動脈症候群治療藥的全球市場 Acute Coronary Syndrome
出版日期: 2019年10月01日內容資訊: 英文 111 Pages
簡介

全球急性冠狀動脈症候群治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 簡介·調查手法·調查範圍

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球急性冠狀動脈症候群市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • AMGEN
  • Astellas Pharma Inc.
  • ASTRAZENECA PLC
  • BIOLOGICAL E.
  • 第一三共
  • DR. REDDY'S LABORATORIES LTD.
  • Eisai
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MOMENTA PHARMACEUTICALS
  • PFIZER, INC
  • RECORDATI SPA
  • THE MEDICINES COMPANY

第5章 調查資料

目錄
Product Code: MCP-6355

Acute Coronary Syndrome market worldwide is projected to grow by US$37.2 Billion, driven by a compounded growth of 13.3%. Acute Coronary Syndrome, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$63.8 Billion by the year 2025, Acute Coronary Syndrome will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.5 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Coronary Syndrome will reach a market size of US$3.5 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.1% over the next couple of years and add approximately US$9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Amgen, Inc.; Astellas Pharma, Inc.; AstraZeneca PLC; Biological E. Ltd.; Daiichi Sankyo Co., Ltd.; Dr. Reddy's Laboratories Ltd.; Eisai Co., Ltd.; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Johnson & Johnson; Momenta Pharmaceuticals, Inc.; Pfizer, Inc.; Recordati SpA; The Medicines Company

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Acute Coronary Syndrome Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Acute Coronary Syndrome Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Acute Coronary Syndrome Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Acute Coronary Syndrome Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • TABLE 4: United States Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 5: Acute Coronary Syndrome Market in the United States: A Historic Review in US$ Million for 2009-2017
  • CANADA
    • TABLE 6: Canadian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 7: Canadian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
  • JAPAN
    • TABLE 8: Japanese Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 9: Acute Coronary Syndrome Market in Japan: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • CHINA
    • TABLE 10: Chinese Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 11: Acute Coronary Syndrome Historic Market Analysis in China in US$ Million: 2009-2017
  • EUROPE
    • Market Facts & Figures
    • TABLE 12: European Acute Coronary Syndrome Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 13: Acute Coronary Syndrome Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 14: European Acute Coronary Syndrome Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 15: Acute Coronary Syndrome Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 16: French Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017
  • GERMANY
    • TABLE 17: Acute Coronary Syndrome Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 18: German Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • ITALY
    • TABLE 19: Italian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 20: Acute Coronary Syndrome Historic Market Analysis in Italy in US$ Million: 2009-2017
  • UNITED KINGDOM
    • TABLE 21: United Kingdom Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 22: Acute Coronary Syndrome Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • SPAIN
    • TABLE 23: Spanish Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 24: Spanish Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
  • RUSSIA
    • TABLE 25: Russian Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 26: Acute Coronary Syndrome Market in Russia: A Historic Review in US$ Million for 2009-2017
  • REST OF EUROPE
    • TABLE 27: Rest of Europe Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 28: Acute Coronary Syndrome Market in Rest of Europe in US$ Million: A Historic Review for the Period 2009-2017
  • ASIA-PACIFIC
    • TABLE 29: Asia-Pacific Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 30: Acute Coronary Syndrome Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 31: Asia-Pacific Acute Coronary Syndrome Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 32: Acute Coronary Syndrome Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 33: Australian Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • INDIA
    • TABLE 34: Indian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 35: Indian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017
  • SOUTH KOREA
    • TABLE 36: Acute Coronary Syndrome Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 37: South Korean Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • REST OF ASIA-PACIFIC
    • TABLE 38: Rest of Asia-Pacific Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 39: Acute Coronary Syndrome Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • LATIN AMERICA
    • TABLE 40: Latin American Acute Coronary Syndrome Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 41: Acute Coronary Syndrome Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 42: Latin American Acute Coronary Syndrome Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 43: Argentinean Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 44: Acute Coronary Syndrome Market in Argentina in US$ Million: A Historic Review for the Period 2009-2017
  • BRAZIL
    • TABLE 45: Acute Coronary Syndrome Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 46: Brazilian Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017
  • MEXICO
    • TABLE 47: Acute Coronary Syndrome Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 48: Mexican Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • REST OF LATIN AMERICA
    • TABLE 49: Rest of Latin America Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 50: Acute Coronary Syndrome Market in Rest of Latin America: A Historic Review in US$ Million for 2009-2017
  • MIDDLE EAST
    • TABLE 51: The Middle East Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 52: Acute Coronary Syndrome Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 53: The Middle East Acute Coronary Syndrome Market Share Breakdown by Region/Country: 2009, 2019, and 2025
  • IRAN
    • TABLE 54: Iranian Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 55: Acute Coronary Syndrome Market in Iran: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • ISRAEL
    • TABLE 56: Israeli Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 57: Acute Coronary Syndrome Market in Israel in US$ Million: A Historic Review for the Period 2009-2017
  • SAUDI ARABIA
    • TABLE 58: Saudi Arabian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 59: Acute Coronary Syndrome Historic Market Analysis in Saudi Arabia in US$ Million: 2009-2017
  • UNITED ARAB EMIRATES
    • TABLE 60: Acute Coronary Syndrome Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 61: United Arab Emirates Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • REST OF MIDDLE EAST
    • TABLE 62: Acute Coronary Syndrome Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 63: Rest of Middle East Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017
  • AFRICA
    • TABLE 64: African Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 65: Acute Coronary Syndrome Market in Africa: A Historic Review in US$ Million for 2009-2017

IV. COMPETITION

  • AMGEN
  • ASTELLAS PHARMA, INC.
  • ASTRAZENECA PLC
  • BIOLOGICAL E.
  • DAIICHI SANKYO CO., LTD.
  • DR. REDDY'S LABORATORIES LTD.
  • EISAI CO.
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MOMENTA PHARMACEUTICALS
  • PFIZER, INC
  • RECORDATI SPA
  • THE MEDICINES COMPANY

V. CURATED RESEARCH

Back to Top